Search hospitals > Wisconsin > Wausau
Aspirus Regional Cancer Center
Claim this profileWausau, Wisconsin 54401
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
207 reported clinical trials
6 medical researchers
Summary
Aspirus Regional Cancer Center is a medical facility located in Wausau, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Aspirus Regional Cancer Center is involved with conducting 207 clinical trials across 226 conditions. There are 6 research doctors associated with this hospital, such as Andrew J. Huang, Harish G. Ahuja, Christopher S. Platta, and Pamela J. Vetter.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
2Lung Cancer
Global LeaderStage II
Stage IV
Stage III
Top PIs
Andrew J. HuangAspirus Regional Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
68 reported clinical trials
141 drugs studied
Harish G. AhujaLanglade Hospital and Cancer Center6 years of reported clinical research
Studies Lung Cancer
Studies Breast Cancer
37 reported clinical trials
86 drugs studied
Christopher S. PlattaAspirus Regional Cancer Center7 years of reported clinical research
Studies Prostate Cancer
Studies Lung Cancer
12 reported clinical trials
38 drugs studied
Pamela J. VetterAspirus Regional Cancer Center6 years of reported clinical research
Studies Prostate Adenocarcinoma
1 reported clinical trial
1 drug studied
Clinical Trials running at Aspirus Regional Cancer Center
Lung Cancer
Prostate Cancer
Breast Cancer
Esophageal cancer
Breast cancer
Pancreatic Cancer
Melanoma
Gastric cancer
Cancer
Skin Cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Aspirus Regional Cancer Center?
Aspirus Regional Cancer Center is a medical facility located in Wausau, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Aspirus Regional Cancer Center is involved with conducting 207 clinical trials across 226 conditions. There are 6 research doctors associated with this hospital, such as Andrew J. Huang, Harish G. Ahuja, Christopher S. Platta, and Pamela J. Vetter.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.